Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

PURPOSE: Neoadjuvant chemotherapy (NAC) plays a pivotal role in the treatment of locally advanced breast cancer (LABC); however, breast cancer is a heterogeneous disease, individual responses to chemotherapy are highly variable. Therefore, the purpose of the current research is to identify biomarker...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancer Manag Res
मुख्य लेखकों: Wang, Xiao-Xiao, Ye, Fu-Gui, Zhang, Jie, Li, Jun-Jing, Chen, Qing-Xia, Lin, Pei-Yang, Song, Chuan-Gui
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2018
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6188109/
https://ncbi.nlm.nih.gov/pubmed/30349372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S172205
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन